Literature DB >> 22923755

Disease impact of hand OA compared with hip, knee and generalized disease in specialist rheumatology health care.

Rikke H Moe1, Margreth Grotle, Ingvild Kjeken, Kåre B Hagen, Tore K Kvien, Till Uhlig.   

Abstract

OBJECTIVE: To describe and compare disease impact in patients with hand OA with those with hip, knee and generalized disease.
METHODS: Patients with OA referred to a specialized rheumatology clinic (408 patients, 86% women) were included in a cross-sectional study. They were examined by a rheumatologist and classified into primary hand, hip, knee and/or generalized (more than two joint localizations) OA. Patient-reported disease impact was collected on numeric rating scales (pain, fatigue), Hopkins Symptom Checklist-25 (emotional distress), Western Ontario and McMaster and Australian/Canadian Hand OA indexes (disease-specific functioning), Short Form 36 (generic health-related quality of life) and a comorbidity checklist.
RESULTS: Considerable disease impact was detected across all localizations: patients scored >5 on pain (range 0-10), had on average two comorbidities and scored >1.5 on emotional distress (Hopkins Symptom Checklist-25, range 1-4). Patients with hand OA scored poor on disease-specific functioning of the lower extremities, and patients with lower extremity OA also scored poor on disease-specific hand functioning. Patients with hand OA scored better on pain (P = 0.001, one-way analyses of variance) and the Short Form 36 Health Survey physical component (P < 0.001), whereas no major differences were observed for the mental component (P = 0.07).
CONCLUSION: OA patients referred to specialist care reported considerable levels of disease impact across localizations. Regardless of functional impairments related to the primary OA localization, patients generally reported high levels of impaired disease-specific functioning at other sites. In the management of OA clinicians should also consider functioning in joint sites other than the primary OA localization. Trial registration. Current controlled trials, www.controlled-trials.com, ISRCTN25778426.

Entities:  

Mesh:

Year:  2012        PMID: 22923755     DOI: 10.1093/rheumatology/kes215

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  4 in total

1.  Defining multiple joint osteoarthritis, its frequency and impact in a community-based cohort.

Authors:  Terese R Gullo; Yvonne M Golightly; Rebecca J Cleveland; Jordan B Renner; Leigh F Callahan; Joanne M Jordan; Virginia B Kraus; Amanda E Nelson
Journal:  Semin Arthritis Rheum       Date:  2018-10-09       Impact factor: 5.532

2.  Distribution of osteoarthritis in a Norwegian population-based cohort: associations to risk factor profiles and health-related quality of life.

Authors:  Guro Økelsrud Lombnæs; Karin Magnusson; Nina Østerås; Lars Nordsletten; May Arna Risberg; Kåre Birger Hagen
Journal:  Rheumatol Int       Date:  2017-04-27       Impact factor: 2.631

3.  The clinical burden of generalized osteoarthritis represented by self-reported health-related quality of life and activity limitations: a cross-sectional study.

Authors:  Nienke Cuperus; Thea P M Vliet Vlieland; Elien A M Mahler; Clarinda C Kersten; Thomas J Hoogeboom; Cornelia H M van den Ende
Journal:  Rheumatol Int       Date:  2014-10-10       Impact factor: 2.631

4.  Multisite peripheral joint pain: a cross-sectional study of prevalence and impact on general health, quality of life, pain intensity and consultation behaviour.

Authors:  Andrew Finney; Krysia S Dziedzic; Martyn Lewis; Emma Healey
Journal:  BMC Musculoskelet Disord       Date:  2017-12-16       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.